REQUEST A DEMO
Total
USD $0.00
Search more companies

Santen Pharma Malaysia Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Management Consulting Services | Management of Companies and Enterprises
Full name: Santen Pharma Malaysia Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Santen Pharma Malaysia Sdn. Bhd. is a company based in Malaysia, with its head office in Kuala Lumpur. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on November 12, 2014. In its most recent financial highlights, the company reported a net sales revenue drop of 7.99% in 2021. Its total assets decreased by 8.02% over the same period. The net profit margin of Santen Pharma Malaysia Sdn. Bhd. increased by 13.16% in 2021.

Headquarters
Unit #23A-10, Q Sentral, No. 2A, Jalan Stesen Sentral 2, Kuala Lumpur Sentral
Kuala Lumpur; Federal Territories; Postal Code: 50470

Contact Details: Purchase the Santen Pharma Malaysia Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Santen Pharma Malaysia Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Santen Pharma Malaysia Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Santen Pharma Malaysia Sdn. Bhd. report to view the information.
Incorporation Date:
November 12, 2014
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Santen Pharma Malaysia Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-7.99%
Total operating revenue
-7.99%
Operating profit (EBIT)
2639.91%
EBITDA
489.25%
Net Profit (Loss) for the Period
4733.37%
Total assets
-8.02%
Total equity
43.82%
Operating Profit Margin (ROS)
7.35%
Net Profit Margin
13.16%
Return on Equity (ROE)
29.56%
Debt to Equity Ratio
-3.54%
Quick Ratio
0.8%
Cash Ratio
0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?